An Open Label Pilot Study of a Dexmedetomidine ‐Remifentanil‐Caudal Anesthetic for Infant Lower Abdominal/Lower Extremity Surgery: The T REX Pilot Study
ConclusionA dexmedetomidine/remifentanil neuraxial anesthetic regimen was effective in 87.5% of infants. These findings can be used as a foundation for designing larger trials that assess alternative anesthetic regimens for anesthetic neurotoxicity in infantsThis article is protected by copyright. All rights reserved.
Source: Pediatric Anesthesia - Category: Anesthesiology Authors: Peter Szmuk,
Dean Andropoulos,
Francis McGowan,
Ansgar Brambrink,
Christopher Lee,
Katherine J Lee,
Mary Ellen McCann,
Yang Liu,
Rita Saynhalath,
Choon Looi Bong,
Brian J Anderson,
Charles Berde,
Jurgen C de Graaff,
Nicola Disma,
Dean Kurth, Tags: Research Report Source Type: research
More News: Anesthesia | Anesthesiology | Brain | Clinical Trials | Diprivan | Hypertension | Neurology | Neurosurgery | Pediatrics | Propofol | Sevoflurane | Study | Toxicology | Ultane